Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1665383

	registered interest
	date	17/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Brain: Tumours
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding the Government has made available for research into paediatric brain tumours in each of the last five years.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Ms Anum Qaisar
	uin	203171
	answer	answer is ministerial correction date of answer 20/10/2023 answer text <p>The Department invests in health research through the National Institute for Health and Care Research (NIHR). NIHR invests in research, clinical expertise, specialist facilities, workforce, and support services across a range of clinical areas. NIHR expenditure on cancer research was over £101 million in 2021/22.</p><p>The Government is committed to funding high-quality brain cancer research. In May 2018 the Government announced £40 million for brain tumour research as part of the Tessa Jowell Brain Cancer Mission through the NIHR. This includes research into paediatric brain tumours.</p><p>The £40 million funding will remain available; if we can spend more on the best quality science, we will do. The level of funding for brain tumour research depends on funding applications received. It is worth noting that all applications to NIHR that have been assessed as “fundable” in open competition have been funded and this will continue.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/10/2023 09:40:25 answering member 4423 label Biography information for Will Quince
	tabling member	4917 label Biography information for Ms Anum Qaisar

1641419

	registered interest
	date	02/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs and Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of ensuring all producers of products registered by the Medicines and Healthcare products Regulatory Agency publish (a) net prices, (b) financial and other contributions to their research and development, (c) patent status, (d) licensing agreements and (e) a summary of contractual access conditions.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Ms Anum Qaisar
	uin	187407
	answer	answer is ministerial correction date of answer 13/06/2023 answer text <p>The MHRA is an independent regulator responsible for granting marketing authorisation to a product following a thorough review of an application submitted by its producer. There is no requirement for producers of these products registered by the MHRA to declare the information referenced, as this information is both commercially sensitive and not required for the MHRA to make an assessment of an application for marketing authorisation.</p> answering member constituency Colchester answering member printed Will Quince question first answered 13/06/2023 12:21:10 answering member 4423 label Biography information for Will Quince
	tabling member	4917 label Biography information for Ms Anum Qaisar

1641420

	registered interest
	date	02/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Infectious Diseases: Disease Control
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the Government supports provisions in the proposed international agreement on pandemic prevention, preparedness and response on (a) public interest conditions on public research &and development funding, b() price transparency and (c) tech transfer of end products.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Ms Anum Qaisar
	uin	187408
	answer	answer is ministerial correction date of answer 13/06/2023 answer text <p>As negotiations on the pandemic instrument are live and in their early stages, we cannot comment on the details of the United Kingdom’s negotiating position. Driving access to safe, affordable essential medical countermeasures is a key priority for the UK in these negotiations, as is ensuring that measures incentivise innovation to strengthen research and development. Officials are working with international partners and non-state actors to ensure the instrument improves access to vaccines, drugs and tests, while also supporting the life sciences sector.</p><p>We have also been clear that the UK will not sign up to a pandemic instrument or any instrument that would compromise the UK’s ability to make domestic decisions on national measures concerning public health policy.</p> answering member constituency Colchester answering member printed Will Quince question first answered 13/06/2023 10:45:06 answering member 4423 label Biography information for Will Quince
	tabling member	4917 label Biography information for Ms Anum Qaisar

1464060

	registered interest
	date	18/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Babies and Mothers: Death
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce the number of (a) maternal and (b) perinatal deaths for women and children from migrant and refugee backgrounds.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Ms Anum Qaisar
	uin	4739
	answer	answer is ministerial correction date of answer 25/05/2022 answer text <p>On 6 September 2021, NHS England published ‘Equity and equality: Guidance for local maternity systems’, which focuses on actions to reduce disparities in health outcomes for women and babies. Local Maternity Systems have been asked to plan interventions to improve equity for mothers and babies, which will benefit inclusion groups such as migrants and refugees. The guidance asks Local Maternity Systems to ensure equity in access, experience and health outcomes and address the leading causes of perinatal mortality and morbidity for babies from black, Asian and minority ethnic groups and those living in the most deprived areas. NHS England has provided £6.8 million to support Local Maternity Systems to implement these plans.</p><p>The Office for Health Improvement and Disparities’ guidance ‘Language Interpreting and Translation: Migrant Health Guide’ gives advice on health needs of migrant patients for healthcare practitioners. The guidance states it is the responsibility of NHS service providers to ensure interpreting and translation services are made available to patients free at the point of delivery. Healthcare employers should advise staff on the arrangements for local interpretation services.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 25/05/2022 13:23:25 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4917 label Biography information for Ms Anum Qaisar

1470057

	registered interest
	date	14/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of prescribing medicinal cannabis on the NHS.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Ms Anum Qaisar
	uin	900476
	answer	answer is ministerial correction date of answer 14/06/2022 answer text <p>Licenced cannabis-based medicines are routinely prescribed and funded on the NHS. However, the latest National Institute for Health and Care Excellence guidelines (written in 2019), demonstrate a clear need for more evidence to support routine prescribing and funding for unlicensed cannabis-based products.</p><p>We are working with regulatory, research and NHS partners to establish clinical trials to prove products safe and effective. We need the cannabis industry to come forward and work with us on this.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/06/2022 15:29:31 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4917 label Biography information for Ms Anum Qaisar

1219276

	registered interest
	date	30/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vitamin D
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has (a) commissioned and (b) undertaken an assessment of the scientific evidence in relation to the effect of lower levels of vitamin D on susceptibility to infection with covid-19.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Neil Gray
	uin	66868
	answer	answer is ministerial correction date of answer 13/07/2020 answer text <p>Public Health England (PHE) commissioned the Scientific Advisory Commission on Nutrition (SACN) to examine new evidence on whether vitamin D supplementation could reduce the risk of Acute Respiratory Tract Infections (ARTIs). SACN’s review concluded that evidence currently does not support vitamin D supplementation to prevent ARTIs in the general United Kingdom population. The review reiterates the importance of vitamin D for bone and muscle health. This can be accessed at the following link:</p><p><a href="https://app.box.com/s/g0ldpth1upfd7fw763ew3aqa3c0pyvky" target="_blank">https://app.box.com/s/g0ldpth1upfd7fw763ew3aqa3c0pyvky</a></p><p>PHE supported National Institute for Health and Care Excellence (NICE) to review emerging evidence on vitamin D and the prevention and treatment of COVID-19. NICE’s review concluded that there is currently no evidence to support taking vitamin D supplements to reduce the risk or severity of COVID-19. This can be accessed at the following link:</p><p><a href="http://www.nice.org.uk/advice/es28/evidence/evidence-review-pdf-8777674477" target="_blank">www.nice.org.uk/advice/es28/evidence/evidence-review-pdf-8777674477</a></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 13/07/2020 14:03:00 answering member 4380 label Biography information for Jo Churchill previous answer version 35075 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527
	tabling member	4365 label Biography information for Neil Gray

1453209

	registered interest
	date	22/03/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Members: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when he plans to reply to the correspondence from the hon. Member for Airdrie and Shotts dated 10 December 2021, 20 December 2021, 11 January 2022, 8 February 2022 and 3 March 2022 on developing a four-nation approach to improving research and funding into childhood cancer.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Ms Anum Qaisar
	uin	145081
	answer	answer is ministerial correction date of answer 24/03/2022 answer text <p>We replied to the hon. Member on 22 March 2022.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 24/03/2022 17:40:01 answering member 4362 label Biography information for Edward Argar
	tabling member	4917 label Biography information for Ms Anum Qaisar

1696834

	registered interest
	date	18/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Polio
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what information her Department holds on the number of patients who (a) have had polio and (b) have post-polio syndrome in the latest period for which data is available.
	tabling member constituency	Airdrie and Shotts
	tabling member printed	Ms Anum Qaisar
	uin	19226
	answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>The Department does not hold data on the number of patients who have had polio or post-polio syndrome. However, the Department does hold data on the number of admissions to hospital, where polio or post-polio syndrome was recorded as a diagnosis, from 2018 to 2023:</p><p>- in 2018/19, there were 176 admissions to National Health Service hospitals in England where polio was recorded as the diagnosis, and 797 admissions where post-polio syndrome was recorded as the diagnosis;</p><p>- in 2019/20, there were 187 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 813 admissions where post-polio syndrome was recorded as the diagnosis;</p><p>- in 2020/21, there were 107 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 522 admissions where post-polio syndrome was recorded as the diagnosis;</p><p>- in 2021/22, there were 115 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 630 admissions where post-polio syndrome was recorded as the diagnosis; and</p><p>- in 2022/23, there were 104 admissions to NHS hospitals in England where polio was recorded as the diagnosis, and 632 admissions where post-polio syndrome was recorded as the diagnosis.</p><p>It is important to note that the number of admissions does not represent the number of patients, as a person may have more than one admission within the period. It is estimated that there are approximately 120,000 people living in the United Kingdom who survived polio when they were younger. Some of these have, or will develop, post-polio syndrome.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 28/03/2024 11:43:41 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4917 label Biography information for Ms Anum Qaisar